Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00674999Phase 3Withdrawn
Phase 3, randomised, open-label trial of biological amniotic membrane in partial-thickness burn (3 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Length of time to 95% healing of treated burn wounds. Planned start Jun 2005; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00674999.